Shoppers Drug Mart Corporation to file 2009 audited financial statements and
Management's Discussion and Analysis on SEDAR

TORONTO, March 11 /CNW/ - Shoppers Drug Mart Corporation (TSX: SC) today announced that its audited financial statements and Management's Discussion and Analysis for its fiscal year ended January 2, 2010 have been filed with Canadian Securities Administrators and will be available at www.sedar.com.

The Company also wishes to notify its shareholders that its 2009 Annual Report, Notice of Annual Meeting of Shareholders, Management Proxy Circular and related materials will be mailed to them by no later than April 2, 2010.

About Shoppers Drug Mart Corporation

Shoppers Drug Mart Corporation is one of the most recognized and trusted names in Canadian retailing. The Company is the licensor of full-service retail drug stores operating under the name Shoppers Drug Mart (Pharmaprix in Québec). With more than 1,170 Shoppers Drug Mart and Pharmaprix stores operating in prime locations in each province and two territories, the Company is one of the most convenient retailers in Canada. The Company also licenses or owns more than 49 medical clinic pharmacies operating under the name Shoppers Simply Pharmacy (Pharmaprix Simplement Santé in Québec) and six luxury beauty destinations operating as Murale. As well, the Company also owns and operates 66 Shoppers Home Health Care stores, making it the largest Canadian retailer of home health care products and services. In addition to its retail store network, the Company owns Shoppers Drug Mart Specialty Health Network Inc., a provider of specialty drug distribution, pharmacy and comprehensive patient support services, and MediSystem Technologies Inc., a provider of pharmaceutical products and services to long-term care facilities in Ontario and Alberta.

For more information, visit www.shoppersdrugmart.ca.

%SEDAR: 00016987E

For further information: Media Contact: Tammy Smitham, Director, Communications & Corporate Affairs, [phone], or [email protected], [phone], ext. 5500; Investor Relations: [phone], ext. 5678, [email protected]